Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.83% | $192.13M | €346.61B | 38.18% | 78 Outperform | |
| SAP SE | 1.93% | $130.96M | €273.22B | 4.56% | 73 Outperform | |
| Nestlé SA | 1.76% | $119.21M | CHF200.57B | 2.56% | 65 Neutral | |
| AstraZeneca | 1.74% | $117.96M | £192.33B | 7.56% | 75 Outperform | |
| HSBC Holdings | 1.66% | $112.97M | £180.66B | 47.15% | 79 Outperform | |
| Novartis AG | 1.60% | $108.59M | CHF188.17B | 3.27% | 78 Outperform | |
| Roche Holding AG | 1.57% | $106.62M | CHF209.25B | 3.87% | 73 Outperform | |
| Shell (UK) | 1.51% | $102.41M | £163.15B | 14.14% | 77 Outperform | |
| Siemens | 1.48% | $100.74M | €192.86B | 35.64% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.22% | $82.87M | €305.51B | -3.84% | 78 Outperform |